Stay updated on Pembrolizumab in mHSPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.

Latest updates to the Pembrolizumab in mHSPC Clinical Trial page
- Check2 days agoChange DetectedThe page’s displayed software/UI revision number was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision history updated with the addition of v3.5.0 and removal of v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check53 days agoChange DetectedNew version entries appear in the Record History, reflecting updates such as recruitment status and IPD sharing metadata. No substantive study data or results are changed in these updates.SummaryDifference0.1%

- Check74 days agoChange DetectedNew revision entry v3.4.2 was added to the history and the government funding notice and Revision: v3.4.1 were removed; these changes are administrative and relate to page display and record-keeping rather than the underlying study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Pembrolizumab in mHSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.